Chemeq says it will meet production requirements

By Melissa Trudinger
Tuesday, 08 March, 2005

Chemeq (ASX:CMQ) has clarified its current and future production capabilities after questions were raised in a research report about the ability of the company to produce the levels of product required by new investment partner Mizuho.

As one of the conditions of the company's AUD$60 million rescue by Mizuho, Chemeq is required to obtain confirmed sales orders for a minimum of 40,000 litres of its polymeric antimicrobial in the 2005-2006 financial year by the end of September this year.

But a recent issue of biotech investor newsletter Bioshares questioned whether the company's production levels were adequate to meet this.

Now the company has confirmed that its current production levels are 60,000-100,000 litres of product, which equates to approximately 15-25 per cent of plant capacity. Ultimately, the plant is expected to reach a production output of 400,000 litres of finished product.

Related News

Unhealthy Western diet could accelerate cognitive decline

An unhealthy Western-style diet is associated with a faster cognitive decline in people with a...

Cancer drug enters clinical trials based on a false mechanism

A cancer drug currently being tested in patients appears to have entered clinical trials based on...

Russia insists there is "no plague case" following lab worker death

Russian health authorities say there is no evidence that pneumonic plague played a part in the...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd